Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract. Human microbiome modulators are described as modulators that have the potential to modulate the microbiome to render beneficial effect on the human body.
The global human microbiome modulator market has maintained a stable annual growth rate of approximately 6.0% from 2015 to 2017. The market is expected to grow at a compound annual growth rate of 11.6% from 2018 to 2026.
Some government agencies around the world are already reorganizing their regulatory policies and regulations to expand access to advanced and cost-effective medical technologies to reduce economic, social and clinical burdens. Therefore, it is believed that the emergence of precision medical methods is expected to promote a paradigm shift in the healthcare industry. Human microbiome modulators are described as modulators that have the potential to modulate the microbiome to produce beneficial effects on the human body. With the advent of this field, precision care has been significantly enhanced to actually provide beneficial therapeutic effects.
The report details the trend, potential and market size of Human Microbiome Modulators market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Human Microbiome Modulatorsmarket, defines the market attractiveness level of Human Microbiome Modulators market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Human Microbiome Modulators industry, describes the types of Human Microbiome Modulators market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Microbiome Modulators market and the development prospects and opportunities of Human Microbiome Modulators industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Microbiome Modulators market in Chapter 13.
By Player:
Bayer AG
Sanofi
Yakult Honsha Co，Ltd
Probi AB
Hansen Holding A / S
EI du Pont de Nemours
Koninklijke DSM NV
Procter and Gamble Company
BioGaia AB
By Type:
Probiotics and Creams
Prebiotics and Dietary Supplements
Drugs
By End-User:
Digestive Health
Immune Health
Oral Health
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Human Microbiome Modulators Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Human Microbiome Modulators Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Human Microbiome Modulators Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Human Microbiome Modulators Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Human Microbiome Modulators Market Analysis and Outlook to 2022
-
7.1 Global Human Microbiome Modulators Consumption (2017-2022)
-
7.2 United States Human Microbiome Modulators Consumption (2017-2022)
-
7.3 Europe Human Microbiome Modulators Consumption (2017-2022)
-
7.4 China Human Microbiome Modulators Consumption (2017-2022)
-
7.5 Japan Human Microbiome Modulators Consumption (2017-2022)
-
7.6 India Human Microbiome Modulators Consumption (2017-2022)
-
7.7 South Korea Human Microbiome Modulators Consumption (2017-2022)
8 Region and Country-wise Human Microbiome Modulators Market Analysis and Outlook to 2028
-
8.1 Global Human Microbiome Modulators Consumption Forecast (2022-2028)
-
8.2 United States Human Microbiome Modulators Consumption Forecast (2022-2028)
-
8.3 Europe Human Microbiome Modulators Consumption Forecast (2022-2028)
-
8.4 China Human Microbiome Modulators Consumption Forecast (2022-2028)
-
8.5 Japan Human Microbiome Modulators Consumption Forecast (2022-2028)
-
8.6 India Human Microbiome Modulators Consumption Forecast (2022-2028)
-
8.7 South Korea Human Microbiome Modulators Consumption Forecast (2022-2028)
9 Global Human Microbiome Modulators Market Outlook by Types and Applications to 2022
-
9.1 Global Human Microbiome Modulators Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Probiotics and Creams Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Prebiotics and Dietary Supplements Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Microbiome Modulators Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Digestive Health Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Immune Health Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Oral Health Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Human Microbiome Modulators Market Outlook by Types and Applications to 2028
-
10.1 Global Human Microbiome Modulators Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Probiotics and Creams Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Prebiotics and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Human Microbiome Modulators Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Digestive Health Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Immune Health Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Oral Health Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Human Microbiome Modulators Import and Export Analysis (Top 5 Countries)
-
11.1 Global Human Microbiome Modulators Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Human Microbiome Modulators Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Human Microbiome Modulators Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Human Microbiome Modulators Market Competitive Analysis
-
14.1 Bayer AG
-
14.1.1 Bayer AG Company Details
-
14.1.2 Bayer AG Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer AG Human Microbiome Modulators Product and Service
-
14.2 Sanofi
-
14.2.1 Sanofi Company Details
-
14.2.2 Sanofi Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi Human Microbiome Modulators Product and Service
-
14.3 Yakult Honsha Co，Ltd
-
14.3.1 Yakult Honsha Co，Ltd Company Details
-
14.3.2 Yakult Honsha Co，Ltd Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Yakult Honsha Co，Ltd Human Microbiome Modulators Product and Service
-
14.4 Probi AB
-
14.4.1 Probi AB Company Details
-
14.4.2 Probi AB Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Probi AB Human Microbiome Modulators Product and Service
-
14.5 Hansen Holding A / S
-
14.5.1 Hansen Holding A / S Company Details
-
14.5.2 Hansen Holding A / S Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Hansen Holding A / S Human Microbiome Modulators Product and Service
-
14.6 EI du Pont de Nemours
-
14.6.1 EI du Pont de Nemours Company Details
-
14.6.2 EI du Pont de Nemours Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 EI du Pont de Nemours Human Microbiome Modulators Product and Service
-
14.7 Koninklijke DSM NV
-
14.7.1 Koninklijke DSM NV Company Details
-
14.7.2 Koninklijke DSM NV Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Koninklijke DSM NV Human Microbiome Modulators Product and Service
-
14.8 Procter and Gamble Company
-
14.8.1 Procter and Gamble Company Company Details
-
14.8.2 Procter and Gamble Company Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Procter and Gamble Company Human Microbiome Modulators Product and Service
-
14.9 BioGaia AB
-
14.9.1 BioGaia AB Company Details
-
14.9.2 BioGaia AB Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 BioGaia AB Human Microbiome Modulators Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Human Microbiome Modulators
-
Figure Human Microbiome Modulators Picture
-
Table Global Human Microbiome Modulators Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Microbiome Modulators Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Microbiome Modulators Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Human Microbiome Modulators Consumption by Country (2017-2022)
-
Figure United States Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Table Europe Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure China Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure India Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Global Human Microbiome Modulators Consumption Forecast by Country (2022-2028)
-
Figure United States Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Probiotics and Creams Consumption and Growth Rate (2017-2022)
-
Figure Global Prebiotics and Dietary Supplements Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Digestive Health Consumption and Growth Rate (2017-2022)
-
Figure Global Immune Health Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Health Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Probiotics and Creams Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prebiotics and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Digestive Health Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune Health Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Health Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Human Microbiome Modulators Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Human Microbiome Modulators Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Human Microbiome Modulators Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Human Microbiome Modulators Product and Service
-
Table Yakult Honsha Co，Ltd (Foundation Year, Company Profile and etc.)
-
Table Yakult Honsha Co，Ltd Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yakult Honsha Co，Ltd Human Microbiome Modulators Product and Service
-
Table Probi AB (Foundation Year, Company Profile and etc.)
-
Table Probi AB Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Probi AB Human Microbiome Modulators Product and Service
-
Table Hansen Holding A / S (Foundation Year, Company Profile and etc.)
-
Table Hansen Holding A / S Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hansen Holding A / S Human Microbiome Modulators Product and Service
-
Table EI du Pont de Nemours (Foundation Year, Company Profile and etc.)
-
Table EI du Pont de Nemours Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table EI du Pont de Nemours Human Microbiome Modulators Product and Service
-
Table Koninklijke DSM NV (Foundation Year, Company Profile and etc.)
-
Table Koninklijke DSM NV Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Koninklijke DSM NV Human Microbiome Modulators Product and Service
-
Table Procter and Gamble Company (Foundation Year, Company Profile and etc.)
-
Table Procter and Gamble Company Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Procter and Gamble Company Human Microbiome Modulators Product and Service
-
Table BioGaia AB (Foundation Year, Company Profile and etc.)
-
Table BioGaia AB Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioGaia AB Human Microbiome Modulators Product and Service
-
